Gosset 50S ribosomal subunit of bacteria Overview
The **50S ribosomal subunit of bacteria** is the large subunit of the prokaryotic 70S ribosome and is essential for protein synthesis in bacteria[1][5][4]. It is composed of two major ribosomal RNAs (the 23S rRNA and the 5S rRNA) and about 31 ribosomal proteins[5][1]. Its primary biological function is to catalyze peptide bond formation during translation and assist in the assembly and folding of newly synthesized proteins[1][3]. The 50S subunit provides several critical functional sites, including the peptidyl transferase center, the G-protein binding site for translation factors, and the polypeptide exit tunnel[1][3]. Clinically, the bacterial 50S ribosomal subunit is a well-validated **antibiotic target**: several major classes of antibiotics—including macrolides, chloramphenicol, lincosamides, pleuromutilins, and oxazolidinones—exert their bacteriostatic or bactericidal effects by binding to different sites on this subunit and inhibiting protein synthesis[1][4][5]. Resistance mechanisms often involve mutation or methylation of nucleotide residues in 23S rRNA, or increased activity of efflux pumps[4]. Selectivity of antibacterial agents for bacterial versus eukaryotic ribosomes is crucial to minimize toxicity to human cells.
Mechanism of Action
Inhibition of peptide bond formation (peptidyl transferase center); Blocking polypeptide exit channel; Prevention of translocation of peptidyl-tRNA
Biological Functions
Disease Associations
Safety Considerations
- Selectivity required to avoid inhibition of human ribosomes (mitochondrial protein synthesis can be affected due to similarity with bacterial ribosomes)
- Emergence of antibiotic resistance (e.g., methylation or mutations of 23S rRNA, efflux pumps)
Interacting Drugs
Associated Biomarkers
| Biomarker |
|---|
| Mutations or modifications (e.g., methylation) in 23S rRNA may serve as biomarkers for resistance to macrolide antibiotics |